Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. (Q53622998)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. |
scientific article |
Statements
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. (English)
I F Tannock
D Osoba
M R Stockler
D S Ernst
A J Neville
M J Moore
G R Armitage
J J Wilson
P M Venner
C M Coppin
K C Murphy
1 June 1996
14
6
1756-1764